- Did you mean
- conference
Search results - 5 results
COVID-19 vaccine effectiveness against symptomatic infection and hospitalisation in Belgium, July 2021 to May 2022.
CI: 95-96) against Delta to 87% (95% CI: 86-89) against Omicron. VE h against Omicron waned to 73% (95% CI: 71-75) 100-150 days after booster vaccination. While recent prior infections conferred higher ...
Vaccine effectiveness against onward transmission of SARS-CoV2-infection by variant of concern and time since vaccination, Belgian contact tracing, 2021.
adjusted for personal characteristics (age, sex, household), background exposure, calendar week, VOC and time since immunity conferring-event. FINDINGS: VET-estimates were higher for mRNA-vaccines, over 90%, ...
Development of a multiplex immunoassay for simultaneous detection of antigens in DTaP vaccines
Publication Type: Scientific poster, presentation or proceeding Authors: Maxime Vermeulen; Isabelle Feck; Alexandre Dobly Source: Global Conference on Vaccine Research and Developpment, PAGES, ...
Panel discussion on CMC in 'Risk- based strategies to support current health emergency
Publication Type: Scientific poster, presentation or proceeding Authors: Wim Van Molle Source: World Vaccine Conference (EU), Terrapinn, Web based (2020) Health Topics: Effectiveness and safety of ...
Involvement of the Belgian OMCL in the COVID-19 crisis
Publication Type: Scientific poster, presentation or proceeding Authors: Eric Deconinck Source: OMCL annual meeting General Session, EDQM, Issue EDQM, tele conference (2020) Health Topics: ...